The Johnson & Johnson COVID-19 vaccine is administered to a Team Kadena member, April 12, 2021, at Kadena Air Base, Japan. Vaccines for COVID-19 are only available after they’re demonstrated to be safe and effective in large phase-three clinical trials, have been authorized by the U.S. Food and Drug Administration and have been manufactured and distributed safely and securely.